Related Experiment Videos
[Fatal outcome in allopurinol hypersensitivity syndrome]
1Odense Universitetshospital, medicinsk afdeling C.
Ugeskrift for Laeger
|March 11, 1998
Summary
Allopurinol hypersensitivity syndrome can be lethal, causing severe skin reactions and organ damage. Careful control of allopurinol therapy based on kidney function is crucial for patient safety.
Area of Science:
- Pharmacology
- Toxicology
- Nephrology
Background:
- Gout is a common inflammatory condition often treated with urate-lowering drugs like allopurinol.
- Allopurinol is a xanthine oxidase inhibitor used to manage hyperuricemia and prevent gout flares.
Observation:
- A 76-year-old man developed severe allopurinol hypersensitivity syndrome (AHS) after a single gout episode.
- The patient presented with epidermal necrolysis, dermal vasculitis, renal impairment, fever, and gastrointestinal bleeding.
- Pulmonary vasculitis was also suspected, contributing to the fatal outcome.
Findings:
- AHS is a severe, potentially fatal adverse drug reaction to allopurinol.
- The syndrome involves multi-organ system involvement, including skin, kidneys, and gastrointestinal tract.
- Impaired renal function is a critical factor in the development and severity of AHS.
Implications:
- This case highlights the importance of cautious allopurinol prescribing, especially in patients with renal compromise.
- Therapeutic drug monitoring and dose adjustment based on renal function are essential to prevent severe AHS.
- Healthcare providers must be vigilant for early signs of AHS to ensure timely intervention and improve patient outcomes.